I am a trained Behavioral Scientist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members who use drugs to inform my line of research and address key needs identified. My primary appointment is at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine and hold an Affiliate Faculty appointment within the School of Public Health. My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.
Dr. Walukevich-Dienst (hear my name) is a licensed clinical psychologist and an Assistant Professor at the University of Washington.
Her research is focused on identifying psychosocial and contextual factors associated with alcohol and cannabis misuse and co-use among young adults, including social influences (e.g., romantic partners, use partnerships), affect management motives, co-occurring mental health concerns, and high-risk substance use events and contexts.
Dr. Walukevich-Dienst aims to leverage this information to develop and test innovative, technology-informed prevention and intervention efforts to disseminate in real world settings.
She also provides psychotherapy to patients at the University of Washington’s Outpatient Psychiatry Clinic and provides supervision and training to psychology graduate students and psychiatry residents in Cognitive Behavioral Therapy.
Link to Dr. Walukevich-Dienst’s CV.
Nathan Sackett, MD, MS is trained as an addiction psychiatrist, focusing on the intersection between substance use and psychiatric disorders. He attended medical school and nursing school at UCSF, graduate school at UC Berkeley and completed his adult psychiatry residency and addiction psychiatry fellowship at the University of Washington. He is now a junior faculty at the University of Washington in the Department of Psychiatry and Behavioral Sciences where he splits his time between seeing patients and research. Clinically, he works primarily outpatient seeing a range of patients with primary psychiatric issues and substance use disorders. His research focuses on the use of psychedelics to treat substance use disorders with a particular interest in how psychedelics can augment the psychotherapeutic process and facilitate behavioral change. When he is not working, he is spending time with his family and playing in the ocean.
I am a clinical psychologist with board certification in geriatric psychology. I am based in the Geriatrics and Extended Care Service of the VA Puget Sound Healthcare System.
Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
In two decades at UW, Dr. Hartzler’s principal focus has been on the dissemination and implementation of empirically-supported health services for persons with substance use disorders. To date, this includes local, regional, national, and international collaborations, encompassing federally-funded work with diverse community-based settings (i.e., addiction care, mental health, primary and specialty medical care, criminal justice, HIV care, schools, faith-based organizations), including those affiliated with the NIDA Clinical Trials Network. As director of the UW Center for Advancing Addiction Health Services (CAAHS), he oversees a broad portfolio, including: 1) the SAMHSA-funded Northwest Addiction Technology Transfer Center (Northwest ATTC), which provides universal, targeted, and intensive technical assistance to the addiction workforce in Alaska, Idaho, Oregon, and Washington 2) regional contribution to SAMHSA’s national Opioid Response Network (ORN), 3) a host of externally-sponsored implementation projects with single-state authorities as well as other organizations, and 4) contribution to NIH-funded and intramural health services research. In professional endeavors that span a science-to-service continuum, Dr. Hartzler seeks to promote adoption and implementation of useful treatment and recovery practices in community settings where they may benefit persons with substance use disorders.
